vs
Amphastar Pharmaceuticals, Inc.（AMPH）とJ&J SNACK FOODS CORP（JJSF）の財務データ比較。上の社名をクリックして会社を切り替えられます
J&J SNACK FOODS CORPの直近四半期売上が大きい（$343.8M vs $183.1M、Amphastar Pharmaceuticals, Inc.の約1.9倍）。Amphastar Pharmaceuticals, Inc.の純利益率が高く（13.3% vs 0.3%、差は13.1%）。Amphastar Pharmaceuticals, Inc.の前年同期比売上増加率が高い（-1.8% vs -5.2%）。Amphastar Pharmaceuticals, Inc.の直近四半期フリーキャッシュフローが多い（$24.6M vs $17.0M）。過去8四半期でAmphastar Pharmaceuticals, Inc.の売上複合成長率が高い（3.2% vs -2.2%）
Amphastar Pharmaceuticalsは上場されている米国の特殊製薬企業です。2004年5月に設立され、主に吸入剤および鼻腔内投与製品の開発、生産、販売を行っており、特色ある医薬品分野で事業を展開しています。
J&Jスナックフーズ社は米国の有名なブランドスナック菓子・冷凍飲料の製造・販売・流通業者で、本社はニュージャージー州マウントローレルに所在します。米国44州、メキシコ、カナダに175を超える生産・保管・流通拠点を構え、ナスダックグローバルセレクト市場に上場し、国内外の市場に事業を展開しています。
AMPH vs JJSF — 直接比較
損益計算書 — Q4 FY2025 vs Q1 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $183.1M | $343.8M |
| 純利益 | $24.4M | $883.0K |
| 粗利率 | 46.8% | 27.9% |
| 営業利益率 | 19.4% | 0.2% |
| 純利益率 | 13.3% | 0.3% |
| 売上前年比 | -1.8% | -5.2% |
| 純利益前年比 | -35.7% | -82.8% |
| EPS（希薄化後） | $0.51 | $0.05 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $183.1M | $343.8M | ||
| Q3 25 | $191.8M | $410.2M | ||
| Q2 25 | $174.4M | $454.3M | ||
| Q1 25 | $170.5M | $356.1M | ||
| Q4 24 | $186.5M | $362.6M | ||
| Q3 24 | $191.2M | $426.8M | ||
| Q2 24 | $182.4M | $440.0M | ||
| Q1 24 | $171.8M | $359.7M |
| Q4 25 | $24.4M | $883.0K | ||
| Q3 25 | $17.4M | $11.4M | ||
| Q2 25 | $31.0M | $44.2M | ||
| Q1 25 | $25.3M | $4.8M | ||
| Q4 24 | $38.0M | $5.1M | ||
| Q3 24 | $40.4M | $29.6M | ||
| Q2 24 | $37.9M | $36.3M | ||
| Q1 24 | $43.2M | $13.3M |
| Q4 25 | 46.8% | 27.9% | ||
| Q3 25 | 51.4% | 31.7% | ||
| Q2 25 | 49.6% | 33.0% | ||
| Q1 25 | 50.0% | 26.9% | ||
| Q4 24 | 46.5% | 25.9% | ||
| Q3 24 | 53.3% | 31.8% | ||
| Q2 24 | 52.2% | 33.6% | ||
| Q1 24 | 52.4% | 30.1% |
| Q4 25 | 19.4% | 0.2% | ||
| Q3 25 | 13.2% | 2.8% | ||
| Q2 25 | 24.2% | 13.3% | ||
| Q1 25 | 21.9% | 1.7% | ||
| Q4 24 | 24.2% | 1.7% | ||
| Q3 24 | 29.8% | 9.3% | ||
| Q2 24 | 30.3% | 11.4% | ||
| Q1 24 | 27.9% | 5.0% |
| Q4 25 | 13.3% | 0.3% | ||
| Q3 25 | 9.0% | 2.8% | ||
| Q2 25 | 17.8% | 9.7% | ||
| Q1 25 | 14.8% | 1.4% | ||
| Q4 24 | 20.4% | 1.4% | ||
| Q3 24 | 21.1% | 6.9% | ||
| Q2 24 | 20.8% | 8.3% | ||
| Q1 24 | 25.1% | 3.7% |
| Q4 25 | $0.51 | $0.05 | ||
| Q3 25 | $0.37 | $0.59 | ||
| Q2 25 | $0.64 | $2.26 | ||
| Q1 25 | $0.51 | $0.25 | ||
| Q4 24 | $0.74 | $0.26 | ||
| Q3 24 | $0.78 | $1.52 | ||
| Q2 24 | $0.73 | $1.87 | ||
| Q1 24 | $0.81 | $0.69 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $282.8M | $66.8M |
| 総負債低いほど良い | $608.7M | — |
| 株主資本純資産 | $788.8M | $912.9M |
| 総資産 | $1.6B | $1.3B |
| 負債/資本比率低いほどレバレッジが低い | 0.77× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $282.8M | $66.8M | ||
| Q3 25 | $276.2M | $105.9M | ||
| Q2 25 | $231.8M | $77.4M | ||
| Q1 25 | $236.9M | $48.5M | ||
| Q4 24 | $221.6M | $73.6M | ||
| Q3 24 | $250.5M | $73.4M | ||
| Q2 24 | $217.8M | $64.0M | ||
| Q1 24 | $289.6M | $43.6M |
| Q4 25 | $608.7M | — | ||
| Q3 25 | $608.6M | — | ||
| Q2 25 | $607.7M | — | ||
| Q1 25 | $603.9M | — | ||
| Q4 24 | $601.6M | — | ||
| Q3 24 | $596.4M | — | ||
| Q2 24 | $586.9M | — | ||
| Q1 24 | $594.0M | — |
| Q4 25 | $788.8M | $912.9M | ||
| Q3 25 | $776.7M | $966.7M | ||
| Q2 25 | $757.5M | $969.9M | ||
| Q1 25 | $751.3M | $935.0M | ||
| Q4 24 | $732.3M | $946.8M | ||
| Q3 24 | $727.7M | $957.0M | ||
| Q2 24 | $713.3M | $937.9M | ||
| Q1 24 | $672.4M | $915.7M |
| Q4 25 | $1.6B | $1.3B | ||
| Q3 25 | $1.7B | $1.4B | ||
| Q2 25 | $1.6B | $1.4B | ||
| Q1 25 | $1.6B | $1.4B | ||
| Q4 24 | $1.6B | $1.3B | ||
| Q3 24 | $1.5B | $1.4B | ||
| Q2 24 | $1.5B | $1.4B | ||
| Q1 24 | $1.6B | $1.3B |
| Q4 25 | 0.77× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 0.80× | — | ||
| Q1 25 | 0.80× | — | ||
| Q4 24 | 0.82× | — | ||
| Q3 24 | 0.82× | — | ||
| Q2 24 | 0.82× | — | ||
| Q1 24 | 0.88× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $32.9M | $36.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $24.6M | $17.0M |
| FCFマージンFCF / 売上 | 13.4% | 4.9% |
| 設備投資強度設備投資 / 売上 | 4.5% | 5.5% |
| キャッシュ転換率営業CF / 純利益 | 1.35× | 40.73× |
| 直近12ヶ月FCF直近4四半期 | $121.2M | $83.1M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $32.9M | $36.0M | ||
| Q3 25 | $52.6M | $66.4M | ||
| Q2 25 | $35.6M | $51.2M | ||
| Q1 25 | $35.1M | $12.3M | ||
| Q4 24 | $29.0M | $35.2M | ||
| Q3 24 | $60.0M | $46.3M | ||
| Q2 24 | $69.1M | $65.0M | ||
| Q1 24 | $55.3M | $12.7M |
| Q4 25 | $24.6M | $17.0M | ||
| Q3 25 | $47.2M | $44.8M | ||
| Q2 25 | $25.0M | $28.5M | ||
| Q1 25 | $24.4M | $-7.2M | ||
| Q4 24 | $16.6M | $16.1M | ||
| Q3 24 | $46.2M | $29.1M | ||
| Q2 24 | $63.1M | $45.3M | ||
| Q1 24 | $46.5M | $-4.0M |
| Q4 25 | 13.4% | 4.9% | ||
| Q3 25 | 24.6% | 10.9% | ||
| Q2 25 | 14.3% | 6.3% | ||
| Q1 25 | 14.3% | -2.0% | ||
| Q4 24 | 8.9% | 4.4% | ||
| Q3 24 | 24.1% | 6.8% | ||
| Q2 24 | 34.6% | 10.3% | ||
| Q1 24 | 27.1% | -1.1% |
| Q4 25 | 4.5% | 5.5% | ||
| Q3 25 | 2.8% | 5.3% | ||
| Q2 25 | 6.1% | 5.0% | ||
| Q1 25 | 6.3% | 5.5% | ||
| Q4 24 | 6.7% | 5.3% | ||
| Q3 24 | 7.2% | 4.0% | ||
| Q2 24 | 3.3% | 4.5% | ||
| Q1 24 | 5.1% | 4.6% |
| Q4 25 | 1.35× | 40.73× | ||
| Q3 25 | 3.03× | 5.84× | ||
| Q2 25 | 1.15× | 1.16× | ||
| Q1 25 | 1.39× | 2.55× | ||
| Q4 24 | 0.76× | 6.84× | ||
| Q3 24 | 1.48× | 1.56× | ||
| Q2 24 | 1.82× | 1.79× | ||
| Q1 24 | 1.28× | 0.96× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
AMPH
| Other Products | $62.4M | 34% |
| Baqsimi | $46.7M | 26% |
| Primatenemist | $27.9M | 15% |
| Epinephrine | $17.1M | 9% |
| Lidocaine | $14.9M | 8% |
| Glucagon | $14.1M | 8% |
JJSF
| Food Service | $219.2M | 64% |
| Frozen Beverages | $78.7M | 23% |
| Repair And Maintenance Service | $22.5M | 7% |
| Other | $12.7M | 4% |
| Machine Sales | $10.7M | 3% |
